Aventis To Increase Fluzone Supply As Wyeth’s FluShield Exits Market

Aventis-Pasteur is in discussions with FDA and the Centers for Disease Control & Prevention on ways to increase the supply of its influenza vaccine Fluzone following Wyeth's decision to discontinue FluShield